Consolidated Statements of Operations (unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
REVENUES
Product revenue, net	$ 2,034,113	$ 1,026,416	$ 4,140,090	$ 1,896,070
OPERATING EXPENSES
Cost of products sold	97,637	98,707	97,637	185,203
Research and development	5,554,200	4,367,538	10,568,830	10,394,569
Selling, general and administrative	3,032,613	3,174,344	6,232,857	6,683,142
Gain on sale of Vyleesi	(7,823,482)	0	(7,823,482)	0
Gain on purchase commitment	0	(1,027,322)	0	(1,027,322)
Total operating expenses	860,968	6,613,267	9,075,842	16,235,592
Income (loss) from operations	1,173,145	(5,586,851)	(4,935,752)	(14,339,522)
OTHER INCOME (EXPENSE)
Investment income	62,026	186,473	133,656	274,962
Foreign currency (loss) gain	(306,697)	(693,231)	(146,947)	(274,855)
Interest expense	(1,605)	(5,487)	(12,487)	(15,089)
Offering expenses	(696,912)	(1,115,765)	(696,912)	(1,115,765)
Change in fair value of warrant liabilities	(8,073,991)	5,247,308	(7,391,591)	5,247,308
Total other income (expense), net	(9,017,179)	3,619,298	(8,114,281)	4,116,561
(Loss) Income before income taxes	(7,844,034)	(1,967,553)	(13,050,033)	(10,222,961)
Income tax benefit	0	4,674,999	0	4,674,999
NET (LOSS) INCOME	$ (7,844,034)	$ 2,707,446	$ (13,050,033)	$ (5,547,962)
Basic and diluted net (loss) income per common share	$ (0.56)	$ 0.25	$ (0.99)	$ (0.54)
Weighted average number of common shares outstanding used in computing basic and diluted net (loss) income per common share	14,097,757	10,802,863	13,134,228	10,215,616